# OMEROS CORP (OMER) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from OMEROS CORP's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/OMER/mda/fy2025/): filed 2026-03-31; accession 0001437749-26-010636 (https://www.sec.gov/Archives/edgar/data/1285819/000143774926010636/omer20251231_10k.htm); latest 10-K
- [FY 2024 MD&A](/company/OMER/mda/fy2024/): filed 2025-03-31; accession 0001437749-25-010216 (https://www.sec.gov/Archives/edgar/data/1285819/000143774925010216/omer20241231_10k.htm)
- [FY 2023 MD&A](/company/OMER/mda/fy2023/): filed 2024-04-01; accession 0001437749-24-010416 (https://www.sec.gov/Archives/edgar/data/1285819/000143774924010416/omer20231231_10k.htm)
- FY 2022: filed 2023-03-13; accession 0001558370-23-003575 (https://www.sec.gov/Archives/edgar/data/1285819/000155837023003575/omer-20221231x10k.htm); MD&A text quarantined because Item 7 boundaries were low-confidence; no filing narrative is published for this year.
- [FY 2021 MD&A](/company/OMER/mda/fy2021/): filed 2022-03-01; accession 0001558370-22-002582 (https://www.sec.gov/Archives/edgar/data/1285819/000155837022002582/omer-20211231x10k.htm)

Back to /company/OMER/